1. Home
  2. OIS vs AKBA Comparison

OIS vs AKBA Comparison

Compare OIS & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OIS
  • AKBA
  • Stock Information
  • Founded
  • OIS 1995
  • AKBA 2007
  • Country
  • OIS United States
  • AKBA United States
  • Employees
  • OIS N/A
  • AKBA N/A
  • Industry
  • OIS Metal Fabrications
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OIS Industrials
  • AKBA Health Care
  • Exchange
  • OIS Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • OIS 353.2M
  • AKBA 336.2M
  • IPO Year
  • OIS 2001
  • AKBA 2014
  • Fundamental
  • Price
  • OIS $5.42
  • AKBA $1.82
  • Analyst Decision
  • OIS Buy
  • AKBA Strong Buy
  • Analyst Count
  • OIS 3
  • AKBA 2
  • Target Price
  • OIS $6.50
  • AKBA $5.75
  • AVG Volume (30 Days)
  • OIS 651.0K
  • AKBA 2.4M
  • Earning Date
  • OIS 10-30-2024
  • AKBA 11-07-2024
  • Dividend Yield
  • OIS N/A
  • AKBA N/A
  • EPS Growth
  • OIS N/A
  • AKBA N/A
  • EPS
  • OIS N/A
  • AKBA N/A
  • Revenue
  • OIS $736,259,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • OIS N/A
  • AKBA N/A
  • Revenue Next Year
  • OIS N/A
  • AKBA $6.13
  • P/E Ratio
  • OIS N/A
  • AKBA N/A
  • Revenue Growth
  • OIS N/A
  • AKBA N/A
  • 52 Week Low
  • OIS $3.91
  • AKBA $0.80
  • 52 Week High
  • OIS $7.27
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • OIS 62.16
  • AKBA 56.59
  • Support Level
  • OIS $5.22
  • AKBA $1.76
  • Resistance Level
  • OIS $5.46
  • AKBA $2.02
  • Average True Range (ATR)
  • OIS 0.20
  • AKBA 0.11
  • MACD
  • OIS 0.03
  • AKBA -0.02
  • Stochastic Oscillator
  • OIS 80.00
  • AKBA 40.00

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore/Manufactured Products, Well Site Services and Downhole Technologies. It erns maximum revenue from Offshore/Manufactured Products.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: